MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
9813 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-05-18 (mpo-mag.com)
Medtronic Begins Trial for Automated Artificial Pancreas - Medical Product Outsourcing
The glucose regulation system is designed to function independently overnight.
Read more
2025-05-08 (houmatimes.com)
CIS and Terrebonne General are first In The Bayou Region to use the Symplicity Spyral™ Renal Denervation System - The Times of Houma/Thibodaux
"As we look to improve the way we treat patients with hypertension, CIS and Terrebonne General are interested in utilizing the latest technological innovations that meet the needs of patients and physicians," said Dr. Finn. "For people with hypertension, medication and/or lifestyle changes can help reduce blood pressure, but studies have shown that many people still don't have control over this condition.
Read more
2025-03-06 (finanznachrichten.de)
INFORMA MARKETS - ENGINEERING: MD&M West Celebrates 40 Years of Leadership in Manufacturing Showcasing AI, Sustainability and the Future of MedTech
Top attending companies include Edwards Lifesciences, Mattel, Apple, Medtronic and Abbot/Abbvie. ANAHEIM, CA / ACCESS Newswire / March 10, 2025 / MD&M West, a legacy leader in manufacturing excellence
Read more
Used by 100+ compliance teams and analysts